These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 24361266)

  • 1. Toxicity and proapoptotic activity of poly(propylene imine) glycodendrimers in vitro: considering their contrary potential as biocompatible entity and drug molecule in cancer.
    Ziemba B; Franiak-Pietryga I; Pion M; Appelhans D; Muñoz-Fernández MÁ; Voit B; Bryszewska M; Klajnert-Maculewicz B
    Int J Pharm; 2014 Jan; 461(1-2):391-402. PubMed ID: 24361266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of maltotriose-modified poly(propylene imine) dendrimers on the chronic lymphocytic leukemia cells in vitro: dense shell G4 PPI.
    Franiak-Pietryga I; Ziółkowska E; Ziemba B; Appelhans D; Voit B; Szewczyk M; Góra-Tybor J; Robak T; Klajnert B; Bryszewska M
    Mol Pharm; 2013 Jun; 10(6):2490-501. PubMed ID: 23641871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dense shell glycodendrimers as potential nontoxic anti-amyloidogenic agents in Alzheimer's disease. Amyloid-dendrimer aggregates morphology and cell toxicity.
    Klementieva O; Benseny-Cases N; Gella A; Appelhans D; Voit B; Cladera J
    Biomacromolecules; 2011 Nov; 12(11):3903-9. PubMed ID: 21936579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of poly(propylene imine) glycodendrimers on β-amyloid aggregation in vitro and in APP/PS1 transgenic mice, as a model of brain amyloid deposition and Alzheimer's disease.
    Klementieva O; Aso E; Filippini D; Benseny-Cases N; Carmona M; Juvés S; Appelhans D; Cladera J; Ferrer I
    Biomacromolecules; 2013 Oct; 14(10):3570-80. PubMed ID: 24004423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly(propylene imine) dendrimers modified with maltose or maltotriose protect phosphorothioate oligodeoxynucleotides against nuclease activity.
    Drzewińska J; Appelhans D; Voit B; Bryszewska M; Klajnert B
    Biochem Biophys Res Commun; 2012 Oct; 427(1):197-201. PubMed ID: 22995301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction study between maltose-modified PPI dendrimers and lipidic model membranes.
    Wrobel D; Appelhans D; Signorelli M; Wiesner B; Fessas D; Scheler U; Voit B; Maly J
    Biochim Biophys Acta; 2015 Jul; 1848(7):1490-501. PubMed ID: 25843678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of fourth generation poly(propyleneimine) dendrimers on blood cells.
    Ziemba B; Halets I; Shcharbin D; Appelhans D; Voit B; Pieszynski I; Bryszewska M; Klajnert B
    J Biomed Mater Res A; 2012 Nov; 100(11):2870-80. PubMed ID: 22623362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of maltose modified poly(propylene imine) dendrimers on hen egg white lysozyme structure and thermal stability.
    Ciolkowski M; Pałecz B; Appelhans D; Voit B; Klajnert B; Bryszewska M
    Colloids Surf B Biointerfaces; 2012 Jun; 95():103-8. PubMed ID: 22410344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotoxicity of poly(propylene imine) dendrimers.
    Ziemba B; Matuszko G; Appelhans D; Voit B; Bryszewska M; Klajnert B
    Biopolymers; 2012 Aug; 97(8):642-8. PubMed ID: 22605555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycodendrimer PPI as a Potential Drug in Chronic Lymphocytic Leukaemia. The Influence of Glycodendrimer on Apoptosis in In Vitro B-CLL Cells Defined by Microarrays.
    Franiak-Pietryga I; Ziółkowska E; Ziemba B; Appelhans D; Maciejewski H; Voit B; Kaczmarek A; Robak T; Klajnert-Maculewicz B; Cebula-Obrzut B; Smolewski P; Borowiec M; Bryszewska M
    Anticancer Agents Med Chem; 2017; 17(1):102-114. PubMed ID: 27349446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gd-Chelated poly(propylene imine) dendrimers with densely organized maltose shells for enhanced MR imaging applications.
    Xiong Z; Wang Y; Zhu J; He Y; Qu J; Effenberg C; Xia J; Appelhans D; Shi X
    Biomater Sci; 2016 Oct; 4(11):1622-1629. PubMed ID: 27722500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Internalization and intracellular trafficking of poly(propylene imine) glycodendrimers with maltose shell in melanoma cells.
    Filimon A; Sima LE; Appelhans D; Voit B; Negroiu G
    Curr Med Chem; 2012; 19(29):4955-68. PubMed ID: 23033945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maltose modified poly(propylene imine) dendrimers as potential carriers of nucleoside analog 5'-triphosphates.
    Szulc A; Signorelli M; Schiraldi A; Appelhans D; Voit B; Bryszewska M; Klajnert-Maculewicz B; Fessas D
    Int J Pharm; 2015 Nov; 495(2):940-7. PubMed ID: 26456295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sugar-modified poly(propylene imine) dendrimers as drug delivery agents for cytarabine to overcome drug resistance.
    Szulc A; Pulaski L; Appelhans D; Voit B; Klajnert-Maculewicz B
    Int J Pharm; 2016 Nov; 513(1-2):572-583. PubMed ID: 27667754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PPI-G4 Glycodendrimers Upregulate TRAIL-Induced Apoptosis in Chronic Lymphocytic Leukemia Cells.
    Franiak-Pietryga I; Ostrowska K; Maciejewski H; Appelhans D; Misiewicz M; Ziemba B; Bednarek M; Bryszewska M; Borowiec M
    Macromol Biosci; 2017 May; 17(5):. PubMed ID: 27996200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of densely organized maltose shells on the biological properties of poly(propylene imine) dendrimers: new effects dependent on hydrogen bonding.
    Klajnert B; Appelhans D; Komber H; Morgner N; Schwarz S; Richter S; Brutschy B; Ionov M; Tonkikh AK; Bryszewska M; Voit B
    Chemistry; 2008; 14(23):7030-41. PubMed ID: 18576443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of Nitroxide-Conjugated and Non-Conjugated Glycodendrimers with Normal and Cancer Cells and Biocompatibility Studies.
    Andreozzi E; Antonelli A; Cangiotti M; Canonico B; Sfara C; Pianetti A; Bruscolini F; Sahre K; Appelhans D; Papa S; Ottaviani MF
    Bioconjug Chem; 2017 Feb; 28(2):524-538. PubMed ID: 28068077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sugar-Modified Poly(propylene imine) Dendrimers Stimulate the NF-κB Pathway in a Myeloid Cell Line.
    Jatczak-Pawlik I; Gorzkiewicz M; Studzian M; Appelhans D; Voit B; Pulaski L; Klajnert-Maculewicz B
    Pharm Res; 2017 Jan; 34(1):136-147. PubMed ID: 27766462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maltotriose-modified poly(propylene imine) Glycodendrimers as a potential novel platform in the treatment of chronic lymphocytic Leukemia. A proof-of-concept pilot study in the animal model of CLL.
    Franiak-Pietryga I; Ziemba B; Sikorska H; Jander M; Kuncman W; Danilewicz M; Appelhans D; Lewkowicz P; Ostrowska K; Bryszewska M; Borowiec M
    Toxicol Appl Pharmacol; 2020 Sep; 403():115139. PubMed ID: 32687837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of dendriplexes formed by anti-HIV genetic material and poly(propylene imine) dendrimers in the presence of glucosaminoglycans.
    Szewczyk M; Drzewinska J; Dzmitruk V; Shcharbin D; Klajnert B; Appelhans D; Bryszewska M
    J Phys Chem B; 2012 Dec; 116(50):14525-32. PubMed ID: 23199071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.